Presentation is loading. Please wait.

Presentation is loading. Please wait.

Subtitle Text Here Zylon Medical Devices Smaller Is Better Supported by NIH SBIR PHASE II Grant # 5 R44 H 68331-3.

Published byVanessa Honeyman Modified over 9 years ago

Similar presentations

Presentation on theme: "Subtitle Text Here Zylon Medical Devices Smaller Is Better Supported by NIH SBIR PHASE II Grant # 5 R44 H 68331-3."— Presentation transcript:

1 Subtitle Text Here Zylon Medical Devices Smaller Is Better Supported by NIH SBIR PHASE II Grant # 5 R44 H 68331-3

2 Subtitle Text Here

3 Overview The Zylon ® Angioplasty catheter with “ZeroFold” Balloon Innovative cardiovascular device Developed to expand clinical application of percutaneous transluminal coronary angioplasty (PTCA) Based on patented technology Angioplasty balloon catheter with “absolutely the lowest profile” Allows certain previously un-crossable or difficult-to-cross stenosed coronary arteries to be crossable and dilatable with efficacy and precision Supported by NIH SBIR Phase II Grant # 5 R44 H 68331-3

4

5 PTCA Percutaneous Transluminal Coronary Angioplasty (PTCA) Minimally invasive surgical approach For treatment of coronary artery blockages Stenosed artery

6 Current Catheters Current Balloon Catheters As typically used in PTCA procedures Balloon is pre-sized, folded, wrapped and located at end of catheter Catheter is placed across a stenotic lesion Upon presserization, balloon unfolds to force open the stenosis

7 Crossing the Lesion Physician must be able to cross the lesion to dilate the stenosis Any increase in crossing resistance restricts clinical usefulness, especially in these procedures: Small arteries Tight stenoses Chronic Total Occlusion (CTO)

8 Surgery Inability to Cross Lesion Consigns patient to open heart surgery Open heart surgery is effective, but characterized by: High morbidity High Expense Long recovery times The Preferred treatment is the minimally invasive balloon angioplasty procedure

9 The Problem Reducing the profile of the balloon in PTCA catheters still remains clinically significant in interventional cardiology.

10

11 The Zylon ® Solution The Zylon ® PTCA Catheter with ZeroFold Balloon Based on patented technology Utilizes a non folded balloon Inflates to full size after crossing target stenosis Eliminates the folded and wrapped balloon of current angioplasty catheters

12 The Zylon ® Solution Standard Catheter and Balloon Full size balloon attached to catheter shaft Then wrapped and folded to reduce profile Creates region of high cross resistance due to presence of multiple layers of wrapped and folded balloon material

13 The Zylon ® Solution Zylon ® Catheter with Zero Fold Balloon Balloon has NO wrapped or folded material Exhibits smooth, continuous transition from tip to proximal shaft “Absolutely the lowest profile” possible

14 The Zylon ® Solution Inflation Zylon ® “ZeroFold” balloons inflate with predictable radial expansion characteristics High burst strength High flexibility Low axial growth

15 The Zylon ® Solution Zylon ® “ZeroFold” balloon vs. standard folded balloon No Fold Balloon Folded Balloon Inner Lumen

16 The Zylon Solution Upper Catheter 0.024” Hole Test Fail - at distal fold Zylon Catheter 0.024” Hole Test Pass - entire balloon

17 The Zylon Solution Other advantages Improved Pushability Easier crossing, less resistance Flexible Smooth gentle inflation Easier to manufacture Simple, no retraining required Smaller* profile over entire range of coronary balloon catheter sizes (1.5-4.0*)

18 The Zylon Solution Applications CTO Pre-dilation POBA (plain old balloon angioplasty) Stent delivery – lower profile with custom stent Rx, over-the-wire, fixed wire versions

19

20 Intellectual Property The following patents and patent applications have relevance to ZeroFold balloon technology: US 5,900,444, Irradiation Conversion of Thermoplastic to Thermoset Polyurethane. US 6,596,818, Irradiation Conversion of Thermoplastic to Thermoset Polymers. US 6,558,732, Process for producing and implantable apparatus comprising a biomedical device coated with cross-linked TPU. US 6,656,550, Dilatation device of uniform outer diameter. EP 0934007, Irradiation Conversion of Thermoplastic to Thermoset Polymers. Canada 2,267,684, Irradiation Conversion of Thermoplastic to Thermoset Polymers. IS129342, Irradiation Conversion of Thermoplastic to Thermoset Polymers. US 20030212318, Process for producing and implantable apparatus comprising a biomedical device coated with cross-linked TPU. US 20040002729, Irradiation Conversion of Thermoplastic to Thermoset Polymers. US 20040093008, Reduced Profile Medical Balloon Element.

21 Intellectual Property Trademarks Zylon, US 2,174,478 Penetrator US 77315423 Irracure US 2,574,588 Fluorothane US 2,505,088

22 Subtitle Text Here Zylon Corporation 600 Chestnut Ridge Road Chestnut Ridge, NY 10977 845-425-9469 sales@zylon.com Zylon Corporation 600 Chestnut Ridge Road Chestnut Ridge, NY 10977 845-425-9469 sales@zylon.com

Download ppt "Subtitle Text Here Zylon Medical Devices Smaller Is Better Supported by NIH SBIR PHASE II Grant # 5 R44 H 68331-3."

Similar presentations

Copyleft Clinical Trial Results. You Must Redistribute Slides PEPCAD II ISR Study Paclitaxel-eluting devices: randomized comparison of the SeQuent™ please.

Copyleft Clinical Trial Results. You Must Redistribute Slides PEPCAD II ISR Study Paclitaxel-eluting devices: randomized comparison of the SeQuent™ please.
PCI Unmet Clinical Needs

PCI Unmet Clinical Needs
Comparison of Surgical Treatments for Blocked Arteries By-Pass Surgery with Heart-Lung Machine By-Pass Surgery using Off-Pump Technique Angioplasty with.

Comparison of Surgical Treatments for Blocked Arteries By-Pass Surgery with Heart-Lung Machine By-Pass Surgery using Off-Pump Technique Angioplasty with.
W e m a k e i d e a s c o m e a l i v e 001IHP050501 For internal use only Not only a peripheral stent available in Renal sizes...

W e m a k e i d e a s c o m e a l i v e 001IHP For internal use only Not only a peripheral stent available in Renal sizes...
W e m a k e i d e a s c o m e a l i v e For internal use only Covering all your needs for Fem-Pop Interventions.

W e m a k e i d e a s c o m e a l i v e For internal use only Covering all your needs for Fem-Pop Interventions.
ARTS I & II Keith D Dawkins Southampton University Hospital.

ARTS I & II Keith D Dawkins Southampton University Hospital.
Coronary Stent Megan French. What is a Stent A small, mesh-like device made of metal Acts as a support or scaffold, in keeping the vessel open Stent helps.

Coronary Stent Megan French. What is a Stent A small, mesh-like device made of metal Acts as a support or scaffold, in keeping the vessel open Stent helps.
Rotablation or Balloon Immediate and 6 month results of a trial in patients with chronic total coronary occlusion Layth A. Mimish, M. Bakhshi, J. Buraiki,

Rotablation or Balloon Immediate and 6 month results of a trial in patients with chronic total coronary occlusion Layth A. Mimish, M. Bakhshi, J. Buraiki,
Angioplasty’s Fight against Restenosis: Drug Eluting Stents & Bare Metal Stents.

Angioplasty’s Fight against Restenosis: Drug Eluting Stents & Bare Metal Stents.
Self-Expanding Stents VS Balloon-Expanding Stents

Self-Expanding Stents VS Balloon-Expanding Stents
Θεματική ενότητα: Stenting

Θεματική ενότητα: Stenting
2 Introduction Drug-eluting stents have defined a new era in the successful treatment of coronary artery disease However, like any therapy, DES results.

2 Introduction Drug-eluting stents have defined a new era in the successful treatment of coronary artery disease However, like any therapy, DES results.
M.Unverdorben; TCT 2007 1 Problem The treatment of stenoses of small coronary arteries (SVD) and of restenoses after stent deployment (ISR) still show.

M.Unverdorben; TCT Problem The treatment of stenoses of small coronary arteries (SVD) and of restenoses after stent deployment (ISR) still show.
Evaluation of ReeKross balloon catheter in treating iliofemoral artery chronic total occlusions Xinwu Lu Vascular Center of Shanghai Jiaotong University.

Evaluation of ReeKross balloon catheter in treating iliofemoral artery chronic total occlusions Xinwu Lu Vascular Center of Shanghai Jiaotong University.
1 *Report IIB(R) 27/2006 - The CoStar Stent (Conor) was also tested but is not shown in this report as it only presents the commercially available stents.

1 *Report IIB(R) 27/ The CoStar Stent (Conor) was also tested but is not shown in this report as it only presents the commercially available stents.
Angiography By: M.Abid (EE-01083-250) Irfan-ullah(EE-01083-247)

Angiography By: M.Abid (EE ) Irfan-ullah(EE )
October 8, 2010 Management of Venous Occlusion 2010 Seth J Worley MD Management of Venous Occlusion: Tunneling, Venoplasty and Other Tricks Seth J. Worley.

October 8, 2010 Management of Venous Occlusion 2010 Seth J Worley MD Management of Venous Occlusion: Tunneling, Venoplasty and Other Tricks Seth J. Worley.
Cardiac Catheters for Delivery of Cell Suspensions Donald Nick Jensen, DVM, MS Division of Cardiovascular Devices HHS/FDA/CDRH.

Cardiac Catheters for Delivery of Cell Suspensions Donald Nick Jensen, DVM, MS Division of Cardiovascular Devices HHS/FDA/CDRH.
Epidemiology in HK  Stroke is major cause of morbidity and mortality around the world  4th cause of mortality in HK resulting in >3000 deaths every.

Epidemiology in HK  Stroke is major cause of morbidity and mortality around the world  4th cause of mortality in HK resulting in >3000 deaths every.
Confidential: Internal Use only 1 Click to edit Master title style Click to edit Master text styles – Second level Third level – Fourth level » Fifth level.

Confidential: Internal Use only 1 Click to edit Master title style Click to edit Master text styles – Second level Third level – Fourth level » Fifth level.

Similar presentations

Ads by Google